Tenon Medical Shares Rise 42% After Passing FDA Inspection
By Chris Wack
Tenon Medical shares were up 42% at $1.21 after the company passed an FDA Level 2 inspection.
The stock hit its 52-week low of 77 cents on Wednesday, and is down 94% in the past 12 months.
The patient-care company said the U.S. Food and Drug Administration concluded a full Quality System Inspection Technique Level 2 inspection, to assess a medical device manufacturer's compliance with the Quality System Requirements regulations.
At the conclusion of the inspection on Wednesday, the FDA investigator determined the meeting was completed with no observations or objectionable conditions identified. A final report will be issued to the company over the coming weeks.
Write to Chris Wack at chris.wack@wsj.com
(END) Dow Jones Newswires
November 03, 2023 11:04 ET (15:04 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Things We Learned From the Q1 Earnings Season
-
After Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening In the Markets This Week
-
Can the Fed Declare Victory on Inflation?
-
After Earnings, Is Coinbase Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
Is ServiceNow Stock a Buy After Earnings and Its Investor Day?
-
3 Stocks to Buy and 3 Stocks to Sell After Earnings
-
Today’s Market Volatility Could Provide Tomorrow’s Opportunities
-
40 of the Best Investment Picks
-
Tech Stock Dividends Are Changing the Face of Dividend Growth Investing
-
Roblox Earnings: Weakening Engagement Has Weighed On Growth
-
The Best Gaming Stocks to Buy
-
Energy Transfer Earnings: M&A Drives Guidance Increase In Solid Quarter
-
The Best Healthcare Stocks to Buy
-
Going Into Earnings, Is Home Depot Stock a Buy, a Sell, or Fairly Valued?